Unity Biotechnology Inc

-0.05 (-2.59%)
4:16:27 PM EDT: $1.89 +0.01 (+0.53%)
Earnings Announcements

Unity Biotechnology Reports Qtrly Net Loss Per Share Of $0.30

Published: 11/10/2021 14:32 GMT
Unity Biotechnology Inc (UBX) - Unity Biotechnology, Inc. Reports Third Quarter 2021 Financial Results and Business Updates.
Believes Current Cash, Cash Equivalents, and Marketable Securities Are Sufficient to Fund Operations Through Q3 of 2022.
Qtrly Net Loss per Share, Basic and Diluted $0.30.
Q3 Earnings per Share View $-0.37 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.34

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.30

More details on our Analysts Page.